During the COVID-19 pandemic, a staggering 340 million tests for the virus were supplied across the world by a company based in South Korea that specializes in so-called syndromic real-time polymerase ...

A new biotechnology company in McKinney has ambitions to become the world’s first fully integrated platform for polymerase chain reaction (PCR) testing — the same technology behind a common COVID-19 ...